Sumitomo Pharma

Phone: +81 6-6203-5321

Fax: +81-6-6202-6028

Web: https://www.sumitomo-pharma.com/

Type	Public (K.K.)
Traded as	TYO: 4506
Industry	Biotech & Pharmaceuticals
Predecessor	Dainippon Pharmaceutical Sumitomo Pharmaceuticals
Founded	October 1, 2005 (merger of Dainippon Pharmaceutical & Sumitomo Pharmaceuticals)
Headquarters	6-8, Doshomachi 2-chome, Chuo-ku, Osaka, Osaka 541-0045, Japan
Key people	Masayo Tada, (President and CEO)
Products	Diagnostics Food additives Food ingredients Pharmaceuticals Veterinary medicines
Revenue	US$3.76 billion (¥387.69 billion) (FY 2013)
Net income	US$194.94 million (¥20.06 billion) (FY 2013)
Number of employees	7,009 (consolidated) 4,291 (non-consolidated) (as of June 30, 2014)
Website	Official website

To broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide. Management Mission To contribute to healthcare and people's well-being based upon the principles of patient-oriented management and innovative research To continuously strive to maximize corporate value through constant business development and to fulfill shareholder expectations To create an environment in which employees can fulfill their potential and increase their creativity To maintain the trust of society and to contribute to the realization of a better global environment

For detailed contact information visit location pages below.